I was diagnosed as type 1 in 2022 and at the time was found to have a NET which caused Atrophy. I’m being monitored yearly and currently taking Metformin and insulin when needed. I’m trying to maintain a low carb diet which I believe helps me regulate my blood sugar. My research found When a pancreatic neuroendocrine tumor (NET) has damaged the pancreas to the extent that a person is diagnosed with diabetes, the pancreas may exhibit several notable changes:
1. **Visible Tumor Mass:**
- The presence of a tumor or multiple tumors within the pancreas. These can vary in size and appearance, often visible as distinct masses on imaging studies such as CT scans, MRIs, or ultrasounds.
2. **Atrophy or Shrinkage:**
- The pancreas or parts of it may become atrophied (shrunken) due to damage from the tumor, reducing the number of functioning insulin-producing cells.
3. **Fibrosis and Scarring:**
- Areas of fibrosis (scarring) where normal pancreatic tissue has been replaced by scar tissue as a result of chronic inflammation and tumor growth.
4. **Changes in Texture and Density:**
- The texture and density of the pancreatic tissue might be altered, appearing more heterogeneous (mixed) on imaging due to the combination of normal, fibrotic, and tumorous tissues.
5. **Loss of Insulin-Producing Cells:**
- Histological examination (microscopic analysis of tissue samples) would show a reduction in the number of insulin-producing beta cells in the islets of Langerhans.
6. **Altered Blood Supply:**
- Changes in the vascular structure, such as reduced or disrupted blood flow to parts of the pancreas due to tumor growth and associated inflammation.
7. **Calcifications:**
- In some cases, there may be calcifications within the pancreas, which are small, hardened areas of tissue that can occur in response to chronic inflammation or damage.
On imaging studies, these changes might be noted by radiologists and pathologists who interpret the scans and biopsy results. The appearance of the pancreas on these studies, along with clinical and laboratory findings, helps in diagnosing the extent of damage and the presence of diabetes. I’m due for a follow up appointment to check on the latest MRI.
1. **Visible Tumor Mass:**
- The presence of a tumor or multiple tumors within the pancreas. These can vary in size and appearance, often visible as distinct masses on imaging studies such as CT scans, MRIs, or ultrasounds.
2. **Atrophy or Shrinkage:**
- The pancreas or parts of it may become atrophied (shrunken) due to damage from the tumor, reducing the number of functioning insulin-producing cells.
3. **Fibrosis and Scarring:**
- Areas of fibrosis (scarring) where normal pancreatic tissue has been replaced by scar tissue as a result of chronic inflammation and tumor growth.
4. **Changes in Texture and Density:**
- The texture and density of the pancreatic tissue might be altered, appearing more heterogeneous (mixed) on imaging due to the combination of normal, fibrotic, and tumorous tissues.
5. **Loss of Insulin-Producing Cells:**
- Histological examination (microscopic analysis of tissue samples) would show a reduction in the number of insulin-producing beta cells in the islets of Langerhans.
6. **Altered Blood Supply:**
- Changes in the vascular structure, such as reduced or disrupted blood flow to parts of the pancreas due to tumor growth and associated inflammation.
7. **Calcifications:**
- In some cases, there may be calcifications within the pancreas, which are small, hardened areas of tissue that can occur in response to chronic inflammation or damage.
On imaging studies, these changes might be noted by radiologists and pathologists who interpret the scans and biopsy results. The appearance of the pancreas on these studies, along with clinical and laboratory findings, helps in diagnosing the extent of damage and the presence of diabetes. I’m due for a follow up appointment to check on the latest MRI.